US scientists urge overhaul of clinical trials to restore confidenceBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7548.991 (Published 27 April 2006) Cite this as: BMJ 2006;332:991
- Michael Day
The US government's top biomedical scientists have called for an overhaul of clinical trials to protect the public and to restore trust in medicine. After a summit at the National Institutes of Health (NIH), in Maryland, the institutes' director, Elias Zerhouni, warned that failure to spot serious side effects of drugs quickly enough was gradually eroding public trust. He announced an eight point plan designed to improve clinical trials and reduce the likelihood of side effects being swept under the carpet.
A key recommendation is for equal weight to be given to determining the safety as well as the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial